Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
aberrant, acid, America, American, appointed, Asia, begun, biopsy, blockbuster, bound, Celgene, characterized, choice, Cittadine, clearance, composition, concept, constrained, Cooperation, Costa, CSI, device, direction, Dr, efficiency, EMEA, Employment, Europe, explore, Filho, formatted, Fortune, founding, guide, induction, inline, invent, Investigational, isotope, joined, Jose, knowledge, Latin, lenalidomide, light, long, MBA, MD, Medtronic, Merck, metal, newly, NUS, Octavio, overseeing, oversight, Pacific, Page, paragraph, PCT, PCTA, pegfilgrastim, Pinto, played, potency, premier, priority, purity, radiochemical, Radiopharmaceutical, radiotherapeutic, Rafael, ranked, rational, Region, resistant, REVLIMID, role, scarcity, Sensant, Singapore, SonarMed, startup, surging, top, Treaty, unexpected
Removed:
began, China, designated, family, home, nominal, open, remain, strain, surfaced
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view